Clinical trial Recruiting at 1 site Observational Ages 18 and up Women only

Investigating testosterone treatment effects in transgender men and non-binary individuals

Official title: Masculinizing Testosterone Treatment and Effects on Preclinical Cardiovascular Disease, Muscle Strength and Power, Aggression, Physical Fitness and Respiratory Function in Transgender Men,Body Identity Clinic (BIC)

Run by Odense University Hospital · NCT04254354 · Data updated 2026-11-12

This study is testing how testosterone treatment affects the health and well-being of transgender men and non-binary individuals over time.

Quick facts

Study typeObservational
Ages18 Years and up
SexWomen only
Enrollment200 (estimated)
SponsorOdense University Hospital
Academic / other
Locations1 site (Odense)
StatusRecruiting
StartedMarch 3, 2020
Main results expectedJanuary 1, 2044
Study endsJanuary 1, 2044
Registry record updatedAugust 13, 2025
Trial IDNCT04254354 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are transgender men and non-binary persons seeking testosterone treatment.

Probably not a fit

Patients who are not transgender men or non-binary individuals may not receive any benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to explore the effects of testosterone treatment on transgender men and non-binary persons, focusing on various health aspects such as cardiovascular status, muscle strength, aggression, and quality of life. Conducted at the Body Identity Clinic in Denmark, participants will be monitored before and during testosterone therapy over a period of up to ten years. The study seeks to understand the potential development of non-calcified coronary plaque associated with testosterone treatment, contributing to the ongoing discussion about its short- and long-term effects.

Why it matters

Potential benefit: If successful, this study could provide valuable insights into the health impacts of testosterone treatment, guiding safer and more effective care for transgender individuals.

How similar studies have gone: While there is ongoing research in this area, the specific focus on cardiovascular effects and non-calcified coronary plaque in this population is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

Transgender men

Exclusion Criteria:

none

Where it's running

  • Odense University Hospital
    Odense, Denmark
    Recruiting

Study contacts

  • Principal investigator: Marianne Andersen — Odense University Hospital
  • Study coordinator: marianne andersen, Professor
  • Email: msa@rsyd.dk
  • Phone: +4565412502

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.